Modern Chinese Medicine Group Co., Ltd. (01643.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

8.9x

Market Cap

HKD 516.08M

MomentumView details →

1D Return

+3.25%

YTD Return

+55.88%

RSI (14)

41.6

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

8.9x

Market Cap

HKD 516.08M

RSI (14)

41.6

MomentumView details →

1D Return

+3.25%

YTD Return

+55.88%

ProfitabilityView details →

Gross Margin

21.94%

Net Margin

−1.01%

EBITDA Margin

6.65%

ROE (TTM)

−0.73%

ROA (TTM)

−0.67%

Asset Turnover

0.67x

GrowthView details →

Revenue YoY

−52.58%

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

−29.27%

EPS CAGR 3Y

—

EBITDA YoY

−88.80%

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.00x

Current Ratio

8.54x

Quick Ratio

7.79x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

357.90M

Net Income (TTM)

−3.62M

Op. CF (TTM)

78.55M

Latest newsMore news →

Modern Chinese Medicine Group issued a profit warning, expecting a net loss of approximately 25.9 million RMB for the six months ended June 2026, compared to a profit of 2.5 million RMB in the same period last year.12d ago

Similar companies

Beijing Biostar Pharms Co Ltd02563.HK Bristol-Myers Squibb Company CeCELG-RI Fangzhou Inc.06086.HK TYK Medicines, Inc02410.HK 天目药业600671.SH Citius Oncology, Inc.CTOR Find similar companies →

Latest newsMore news →

Modern Chinese Medicine Group issued a profit warning, expecting a net loss of approximately 25.9 million RMB for the six months ended June 2026, compared to a profit of 2.5 million RMB in the same period last year.12d ago